Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    June 2017
  1. SUGAHARA M, Tanaka T, Nangaku M
    Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease.
    Kidney Int. 2017 Jun 24. pii: S0085-2538(17)30305.
    PubMed     Text format     Abstract available


    March 2017
  2. GOODSHIP TH, Cook HT, Fakhouri F, Fervenza FC, et al
    Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Kidney Int. 2017;91:539-551.
    PubMed     Text format     Abstract available


    November 2016
  3. RHEAULT MN, Molony JT, Nevins T, Herzog CA, et al
    Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
    Kidney Int. 2016 Nov 16. pii: S0085-2538(16)30539.
    PubMed     Text format     Abstract available


  4. WYATT CM, Drueke TB
    HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
    Kidney Int. 2016;90:923-925.
    PubMed     Text format     Abstract available


    September 2016
  5. PERGOLA PE, Spinowitz BS, Hartman CS, Maroni BJ, et al
    Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
    Kidney Int. 2016 Sep 17. pii: S0085-2538(16)30357.
    PubMed     Text format     Abstract available


    August 2016
  6. BRIER ME, Gaweda AE
    Artificial intelligence for optimal anemia management in end-stage renal disease.
    Kidney Int. 2016;90:259-61.
    PubMed     Text format     Abstract available


    June 2016
  7. BARBIERI C, Molina M, Ponce P, Tothova M, et al
    An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.
    Kidney Int. 2016 Jun 2. pii: S0085-2538(16)30132.
    PubMed     Text format     Abstract available


    May 2016
  8. MARCELLI D, Bayh I, Merello JI, Ponce P, et al
    Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30056.
    PubMed     Text format     Abstract available


  9. WYATT CM, Drueke TB
    Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?
    Kidney Int. 2016;89:971-3.
    PubMed     Text format     Abstract available


    March 2016
  10. KAVANAGH D, Smith-Jackson K
    Eculizumab in children with hemolytic uremic syndrome.
    Kidney Int. 2016;89:537-8.
    PubMed     Text format     Abstract available


  11. GREENBAUM LA, Fila M, Ardissino G, Al-Akash SI, et al
    Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Kidney Int. 2016;89:701-11.
    PubMed     Text format     Abstract available


    November 2015
  12. MACDOUGALL IC
    Supplemental iron via dialysate: a novel mode of delivery for hemodialysis patients.
    Kidney Int. 2015;88:946-949.
    PubMed     Text format     Abstract available


    October 2015
  13. DRUEKE TB, Massy ZA
    Oral or intravenous iron for anemia correction in chronic kidney disease?
    Kidney Int. 2015;88:673-5.
    PubMed     Text format     Abstract available


    September 2015
  14. GERL K, Miquerol L, Todorov VT, Hugo CP, et al
    Inducible glomerular erythropoietin production in the adult kidney.
    Kidney Int. 2015 Sep 23. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


    June 2015
  15. AGARWAL R, Kusek JW, Pappas MK
    A randomized trial of intravenous and oral iron in chronic kidney disease.
    Kidney Int. 2015 Jun 17. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  16. BARADHI KM, Ahmed S, Buford ML
    The Case | Acute renal failure after antibiotic treatment for bronchitis. Diagnosis: Pigment nephropathy from cephalexin-induced immune hemolytic anemia.
    Kidney Int. 2015;87:1269-70.
    PubMed     Text format    


    May 2015
  17. LICHT C, Greenbaum LA, Muus P, Babu S, et al
    Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.
    Kidney Int. 2015;87:1061-73.
    PubMed     Text format     Abstract available


  18. NESTER CM
    Managing atypical hemolytic uremic syndrome: chapter 2.
    Kidney Int. 2015;87:882-4.
    PubMed     Text format     Abstract available


    January 2015
  19. BAILIE GR, Larkina M, Goodkin DA, Li Y, et al
    Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.
    Kidney Int. 2015;87:162-8.
    PubMed     Text format     Abstract available


    August 2014
  20. PICCOLI GB, Roggero S, De Pascale A, Vigotti FN, et al
    Microhematuria in a patient with beta-thalassemia major: a casual or a causal association?
    Kidney Int. 2014;86:450-2.
    PubMed     Text format    


    April 2014
  21. KURAGANO T, Matsumura O, Matsuda A, Hara T, et al
    Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients.
    Kidney Int. 2014 Apr 23. doi: 10.1038/ki.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: